Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced that the U.S. Food and Drug Administration (FDA) has ...
Display Art PLC Annual stock financials by MarketWatch. View the latest DISP financial statements, income statements and financial ratios.
PHILADELPHIA & SAN FRANCISCO, January 12, 2026--(BUSINESS WIRE)--Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results